The two have collaborated for decades, with Karikó focusing on the RNA side and Weissman handling the immunology: “We educated each other,” she said. Before COVID-19, mRNA vaccines were ...
This is done by introducing a short-lived sliver of genetic information, known as RNA, which, once injected, instructs the body’s cells to manufacture the neoantigens. The resulting immune ...